Clinical Trials Directory

Trials / Unknown

UnknownNCT06058429

Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

Immunogenicity After Primary Immunization and Booster Immunization of Sabin Strain Inactivated Polio Vaccine (Vero Cells) in Infants and Young Children and Enterovirus Serological Monitoring Study

Status
Unknown
Phase
Study type
Observational
Enrollment
233 (actual)
Sponsor
Sinovac Biotech Co., Ltd · Industry
Sex
All
Age
2 Months – 27 Months
Healthy volunteers

Summary

This study was conducted on the basis of "Safety Observation of Sabin Strain Inactivated Polio Vaccine (Vero Cell) on primary Immunization, Booster Immunization and Simultaneous Vaccination with Other Vaccines in Infants and Young Children(ID: PRO-sIPV-MA4001-JX). Blood samples were collected in about 200 qualified subjects 1-9 months after their last vaccination of sIPV. And immunogenicity of sIPV and other vaccines simultaneously administrated will be tested, the antibodies against enterovirus (including EV71、CA16、CA6 and CA10) will also be tested.

Conditions

Interventions

TypeNameDescription
OTHERno interventionThis is an observation study after vaccination, no intervention will be used

Timeline

Start date
2023-08-16
Primary completion
2023-09-07
Completion
2023-12-31
First posted
2023-09-28
Last updated
2023-10-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06058429. Inclusion in this directory is not an endorsement.